cDNA accession Links to the sequence |
Tissue most 5' clones in red |
Match mRNA |
From bp to bp in mRNA |
From bp to bp in accs. |
Clone encodes complete protein (with AA variation) |
Features | Anomalies detected by AceView |
Accession match over (% length) |
Base differences relative to genome (% identity) |
AB021225 | .a | 9 to 2418 | 1 to 2419 | tiling clone, AAA | 2419/2419 (100 %) | 10 diff (99.6 %id) | |||
BC040507 | Brain, hypothalamus | .a | 23 to 2417 | 1 to 2404 | available from MGC, AAA | 2404/2404 (100 %) | 12 diff (99.6 %id) | ||
BC045610 | Brain, hippocampus | .a | 11 to 2418 | 6 to 2422 | tiling clone, available from MGC, AAA | 2417/2417 (100 %) | 12 diff (99.6 %id) | ||
BX091026 | whole brain | .b | 1756 to 2291 | 551 to 15 | AAA | Submitted on the opposite strand | 537/537 (100 %) | 4 diff (99.3 %id) | |
CN267843 | embryonic stem cells, cell lines H1, H7, andH9 | .a | 22 to 166 | 1 to 147 | 147/147 (100 %) | 8 diff (94.6 %id) | |||
BX389435 | Neuroblastoma Cot 25-normalized | .a | 605 to 1491 | 6 to 894 | tiling clone, | 889/894 (99 %) | 8 diff (99.2 %id) | ||
BX440072 | brain, fetal brain | .a | 1329 to 2373 | 1029 to 1 | 1029/1125 (91 %) | 26 diff (97.7 %id) | |||
BX505590 | .g-u | 513 to 690 | 1 to 181 | tiling clone, | 181/181 (100 %) | 4 diff (97.8 %id) | |||
AL119881 | amygdala | .a | 1262 to 1616 | 1 to 356 | 356/356 (100 %) | 1 diff (99.8 %id) | |||
DB475866 | hippocampus | .a | 11 to 231 | 1 to 230 | 230/230 (100 %) | 5 diff (97.9 %id) | |||
BQ638867 | eye, retina | .a | 1519 to 2072 | 1 to 554 | 554/554 (100 %) | 7 diff (98.8 %id) | |||
BY799254 | eye | .a | 1345 to 1977 | 1 to 632 | 632/632 (100 %) | 1 diff (99.9 %id) | |||
M78759 | .a | 1549 to 1879 | 330 to 1 | 330/330 (100 %) | 1 diff (99.7 %id) | ||||
R42600 | whole brain | .b | 2172 to 2292 | 129 to 9 | 121/130 (93 %) | 0 diff (100 %id) | |||
H97792 | melanocyte | .b | 1941 to 2289 | 347 to 3 | 345/347 (99 %) | 0 diff (100 %id) | |||
AA522814 | lung, lung tumor | .b | 1728 to 2292 | 564 to 5 | 560/564 (99 %) | 0 diff (100 %id) | |||
AI539031 | poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus | .b | 2032 to 2291 | 270 to 11 | AAA | 260/260 (100 %) | 5 diff (98.1 %id) | ||
AI760347 | B-cell, chronic lymphotic leukemia | .a | 1680 to 2416 | 734 to 2 | 733/734 (99 %) | 0 diff (100 %id) | |||
AI829838 | lymph node, lymphoma, follicular mixed small and largecell | .a | 1848 to 2416 | 569 to 2 | 568/569 (99 %) | 0 diff (100 %id) | |||
AW168692 | bowel (skin primary), metastatic melanoma to bowel | .b | 2007 to 2289 | 289 to 4 | tiling clone, | 286/289 (98 %) | 0 diff (100 %id) | ||
BF514267 | .b | 2151 to 2291 | 158 to 18 | AAA | 141/141 (100 %) | 1 diff (99.3 %id) | |||
BF515166 | .b | 2160 to 2291 | 149 to 18 | AAA | 132/141 (93 %) | 1 diff (99.3 %id) | |||
BE281640 | choriocarcinoma, placenta | .c | 1077 to 1778 | 22 to 723 | tiling clone, | 702/772 (90 %) | 26 diff (96.7 %id) | ||
BF347731 | anaplastic oligodendroglioma with 1p/19qloss, brain | .a | 964 to 1715 | 1 to 745 | 745/957 (77 %) | 26 diff (97.3 %id) | |||
BG118062 | adenocarcinoma, cell line, Liver | .a | 2094 to 2143 | 1 to 50 | 50/50 (100 %) | 0 diff (100 %id) | |||
BG251251 | adenocarcinoma, cell line, Liver | .d | 195 to 925 | 1 to 725 | tiling clone, | 725/970 (74 %) | 13 diff (98.7 %id) | ||
BM083678 | melanotic melanoma, skin | .c | 541 to 1200 | 1 to 660 | 660/660 (100 %) | 2 diff (99.7 %id) | |||
BG478782 | melanotic melanoma, skin | .c | 541 to 1382 | 1 to 851 | tiling clone, | 851/956 (89 %) | 18 diff (98.2 %id) | ||
BG768359 | melanotic melanoma, high MDR (cell line), skin | .a | 954 to 1675 | 1 to 720 | 722/721 (100 %) | 11 diff (98.5 %id) | |||
BG819285 | anaplastic oligodendroglioma with 1p/19qloss, brain | .b | 2044 to 2291 | 1 to 249 | AAA | 249/249 (100 %) | 2 diff (99.2 %id) | ||
BI551593 | brain, hippocampus | .a | 1 to 644 | 1 to 658 | 658/658 (100 %) | 13 diff (98.1 %id) | |||
BM015637 | breast, mammary adenocarcinoma, cell line | .d | 2 to 661 | 1 to 659 | tiling clone, | 659/659 (100 %) | 1 diff (99.9 %id) | ||
BQ227546 | melanotic melanoma, skin | .a | 1789 to 2418 | 1 to 630 | AAA | 630/630 (100 %) | 2 diff (99.7 %id) | ||
BU167886 | melanotic melanoma, cell line, skin | .a | 1233 to 2017 | 1 to 787 | 787/1017 (77 %) | 17 diff (98.4 %id) | |||
BU179230 | melanotic melanoma, cell line, skin | .a | 1233 to 2120 | 1 to 892 | 892/919 (97 %) | 24 diff (97.4 %id) | |||
BU159935 | eye, retinoblastoma | .b | 2081 to 2291 | 11 to 221 | AAA | 211/221 (95 %) | 0 diff (100 %id) | ||
BQ953874 | sciatic nerve | .a | 1360 to 2059 | 24 to 734 | 711/919 (77 %) | 22 diff (97.7 %id) | |||
BQ680344 | melanotic melanoma, cell line, skin | .a | 1233 to 2161 | 1 to 937 | 937/982 (95 %) | 35 diff (96.5 %id) | |||
BQ678947 | melanotic melanoma, cell line, skin | .a | 1233 to 1871 | 1 to 640 | 640/886 (72 %) | 18 diff (98.0 %id) | |||
BQ949787 | large cell carcinoma, lung | .a | 1569 to 2418 | 875 to 21 | AAA | Submitted on the opposite strand | 855/888 (96 %) | 12 diff (98.7 %id) | |
CA489162 | .a | 420 to 1264 | 27 to 877 | 851/933 (91 %) | 23 diff (97.6 %id) | ||||
CX164260 | human embryonic stem cells differentiated toan early endodermal cell type | .c | 1 to 775 | 1 to 784 | tiling clone, | 784/784 (100 %) | 5 diff (99.4 %id) | ||
CX783961 | human embryonic stem cells | .f | 1 to 711 | 1 to 711 | T6P | tiling clone, | 711/711 (100 %) | 2 diff (99.8 %id) | |
TI_44171005 | .a | 2 to 644 | 121 to 777 | 657/777 (84 %) | 4 diff (99.5 %id) | ||||
TI_59393892 | .d | 1 to 661 | 86 to 745 | tiling clone, | 660/660 (100 %) | 1 diff (99.9 %id) | |||
NM_016155.4 | .a | 9 to 2418 | 1 to 2410 | RefSeq, AAA | 2410/2410 (100 %) | 2 diff (100.0 %id) | |||
DA738039 | .e | 1 to 753 | 2 to 759 | tiling clone, capped | 758/763 (99 %) | 12 diff (98.5 %id) | |||
DB370648 | .e | 1259 to 1785 | 536 to 3 | tiling clone, | 534/580 (92 %) | 22 diff (96.3 %id) | |||
DR007226 | testis | .a | 159 to 704 | 18 to 563 | tiling clone, | 546/563 (96 %) | 1 diff (99.9 %id) | ||
CB853326 | Human Lung Epithelial cells, lung | .a | 1745 to 2418 | 696 to 19 | tiling clone, AAA | 678/678 (100 %) | 12 diff (98.3 %id) | ||
DB269753 | uterus | .g-u | 1 to 549 | 2 to 550 | tiling clone, capped | 549/549 (100 %) | 0 diff (100 %id) | ||
X89576 | breast carcinoma | .b | 1 to 2301 | 1 to 2301 | A162T | tiling clone, | 2301/2306 (99 %) | 6 diff (99.8 %id) | |
BX375177 | Neuroblastoma Cot 25-normalized | .a | 1233 to 2120 | 1 to 892 | Suspected internal deletion, this clone was ignored | 892/919 (97 %) | 24 diff (97.4 %id) | ||
BX440073 | brain, fetal brain | .a | 1233 to 2120 | 1 to 892 | This clone was ignored | 892/919 (97 %) | 24 diff (97.4 %id) | ||
BX440074 | brain, fetal brain | .b | 2081 to 2291 | 11 to 221 | This clone was ignored | 211/221 (95 %) | 0 diff (100 %id) | ||
T77190 | whole brain | .b | 2081 to 2291 | 11 to 221 | 211/221 (95 %) | 0 diff (100 %id) | |||
BG478494 | melanotic melanoma, skin | .a | 1360 to 2059 | 24 to 734 | Suspected internal deletion, this clone was ignored | 711/919 (77 %) | 22 diff (97.7 %id) | ||
BQ680344 | melanotic melanoma, cell line, skin | .a | 1233 to 2161 | 1 to 937 | 937/982 (95 %) | 35 diff (96.5 %id) | |||
BQ680344 | melanotic melanoma, cell line, skin | .a | 1233 to 2161 | 1 to 937 | 937/982 (95 %) | 35 diff (96.5 %id) | |||
BQ678947 | melanotic melanoma, cell line, skin | .a | 1233 to 1871 | 1 to 640 | 640/886 (72 %) | 18 diff (98.0 %id) | |||
BQ678947 | melanotic melanoma, cell line, skin | .a | 1233 to 1871 | 1 to 640 | 640/886 (72 %) | 18 diff (98.0 %id) | |||
BQ949787 | large cell carcinoma, lung | .a | 1569 to 2418 | 875 to 21 | AAA | Submitted on the opposite strand | 855/888 (96 %) | 12 diff (98.7 %id) | |
BQ949787 | large cell carcinoma, lung | .a | 1569 to 2418 | 875 to 21 | AAA | Submitted on the opposite strand | 855/888 (96 %) | 12 diff (98.7 %id) | |
CA489162 | .a | 420 to 1264 | 27 to 877 | 851/933 (91 %) | 23 diff (97.6 %id) | ||||
CX164260 | human embryonic stem cells differentiated toan early endodermal cell type | .c | 1 to 775 | 1 to 784 | tiling clone, | 784/784 (100 %) | 5 diff (99.4 %id) | ||
CX783961 | human embryonic stem cells | .f | 1 to 711 | 1 to 711 | T6P | tiling clone, | 711/711 (100 %) | 2 diff (99.8 %id) | |
TI_44171005 | .a | 2 to 644 | 121 to 777 | 657/777 (84 %) | 4 diff (99.5 %id) | ||||
TI_59393892 | .d | 1 to 661 | 86 to 745 | tiling clone, | 660/660 (100 %) | 1 diff (99.9 %id) | |||
NM_016155.4 | .a | 9 to 2418 | 1 to 2410 | RefSeq, AAA | 2410/2410 (100 %) | 2 diff (100.0 %id) | |||
DA738039 | .e | 1 to 753 | 2 to 759 | tiling clone, capped | 758/763 (99 %) | 12 diff (98.5 %id) | |||
DB370648 | .e | 1259 to 1785 | 536 to 3 | tiling clone, | 534/580 (92 %) | 22 diff (96.3 %id) | |||
DR007226 | testis | .a | 159 to 704 | 18 to 563 | tiling clone, | 546/563 (96 %) | 1 diff (99.9 %id) | ||
CB853326 | Human Lung Epithelial cells, lung | .a | 1745 to 2418 | 696 to 19 | tiling clone, AAA | 678/678 (100 %) | 12 diff (98.3 %id) | ||
CB853326 | Human Lung Epithelial cells, lung | .a | 1745 to 2418 | 696 to 19 | tiling clone, AAA | 678/678 (100 %) | 12 diff (98.3 %id) | ||
DB269753 | uterus | .g-u | 1 to 549 | 2 to 550 | tiling clone, capped | 549/549 (100 %) | 0 diff (100 %id) | ||
X89576 | breast carcinoma | .b | 1 to 2301 | 1 to 2301 | A162T | tiling clone, | 2301/2306 (99 %) | 6 diff (99.8 %id) |
? | Gene Summary | Gene on genome | mRNA:.a, .b, .c, .d, .e, .f, .g-u, .h-u | Alternative mRNAs features, proteins, introns, exons, sequences | Expression Tissue | Function, regulation, related genes DCI |